Walleye Capital’s PhenomeX Inc. Common Stock CELL Stock Holding History

Walleye Capital’s Portfolio CELL Stock Details CELL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-23,867	Closed	-$170K	–	2798
2022 Q1	$170K	Buy	+23,867	New	+$197K	﹤0.01%	1585
2021 Q3	–	Sell	-11,685	Closed	-$524	–	1885
2021 Q2	$524	Sell	11,685 -15,459	-57%	-$717K	0.02%	732
2021 Q1	$1.36K	Buy	+27,144	New	+$1.85M	0.08%	215

Other funds holding CELL

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Walleye Capital's CELL Position: Q2 2022 in Review

Walleye Capital sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2022, closing a stake of 23,867 shares — an estimated $170K sold.

Walleye Capital first reported a position in CELL in Q1 2021 and held it in 3 quarters. The position peaked at $170K in Q1 2022. 123 funds tracked by Wall St. Rank hold CELL as of Q2 2022.

Walleye Capital reported no remaining PhenomeX Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Walleye Capital sold 23,867 PhenomeX Inc. Common Stock shares in Q2 2022, an estimated $170K.
Walleye Capital first reported a position in PhenomeX Inc. Common Stock in Q1 2021 and held it in 3 quarters.
Walleye Capital's PhenomeX Inc. Common Stock position peaked at $170K in Q1 2022.
123 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2022.

Based on Walleye Capital's 13F filing for Q2 2022, filed 8 Aug 2022.